Mounjaro 5 mg Pfs image 1
01 / 04

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·MOUNJARO
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·MOUNJAROWeight Loss Medicines

Mounjaro 5 mg Pfs

Tirzepatide is a prescription injection used to control blood sugar in adults with type 2 diabetes. A brand version is also approved for long-term weight management in adults with obesity or overweight with weight-related health problems, and for obstructive sleep apnea in adults with obesity. It works by acting like two natural gut hormones (GIP and GLP-1), which increase insulin release, lower appetite, and slow stomach emptying. It is injected under the skin once a week and used along with a healthy diet and exercise.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Tirzepatide is a dual GIP and GLP-1 receptor agonist, so it activates two hormone pathways that help the body control blood sugar and appetite. It increases insulin release only when blood sugar is high, reduces the amount of sugar made by the liver, and makes people feel full for longer. It is prescribed for type 2 diabetes, and for chronic weight management and obstructive sleep apnea in adults with obesity under separate brand approvals. It is supplied as a prefilled pen or syringe and injected under the skin of the abdomen, thigh, or upper arm once a week, on the same day each week, with or without food. Treatment starts at a low dose of 2.5 mg weekly for four weeks and is increased gradually in steps of 2.5 mg at least every four weeks, up to a maximum of 15 mg, as directed by the doctor. The injection site should be rotated each week, and a missed dose can usually be taken within 4 days of the missed day. Common side effects include nausea, vomiting, diarrhea, constipation, stomach pain, loss of appetite, and indigestion, which are most common during dose increases and usually ease with time. Serious risks include pancreatitis, gallbladder problems, kidney injury from dehydration, and worsening of diabetic eye disease, so severe stomach pain, persistent vomiting, or vision changes need urgent medical care. It can cause low blood sugar when combined with insulin or sulfonylureas, so those doses may need to be reduced. It carries a warning for thyroid C-cell tumors, and it must not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2. It may reduce the effect of oral birth control pills, so women should use a backup method for four weeks after starting and after each dose increase. It should be avoided in pregnancy and breastfeeding, and unsupervised use of compounded or non-regulated products is unsafe. Pens should be stored in a refrigerator and the dose should never be changed without medical advice.

Specifications

Composition
Tirzepatide
Strength
5 mg
Manufacturer
lilly
Treatment
Type 2 Diabetes and Weight Loss
Packaging Type
Pfs
Packaging Size
1 Pfs

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products